(NASDAQ: EDSA) Edesa Biotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 56.52%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 101.52%.
Edesa Biotech's earnings in 2025 is -$5,837,964.On average, 5 Wall Street analysts forecast EDSA's earnings for 2026 to be -$14,970,945, with the lowest EDSA earnings forecast at -$24,913,652, and the highest EDSA earnings forecast at -$4,129,335.
In 2027, EDSA is forecast to generate -$12,857,821 in earnings, with the lowest earnings forecast at -$21,610,185 and the highest earnings forecast at -$3,318,215.